Ping Du
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
- Epidemiology 23
- HIV, Drug Use, Sexual Risk 6
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 5
- Co-authors
- Paddy Ssentongo (11 shared papers)Vernon M. Chinchilli (8 shared papers)Anna E. Ssentongo (7 shared papers)Jintong Liu (1 shared paper)Lei Zhang (1 shared paper)Jianping Lei (1 shared paper)Emily S. Heilbrunn (5 shared papers)Hugh D. C. Smyth (4 shared papers)
- Journals
- Sexually Transmitted Diseases (4 papers)American Journal of Infection Control (4 papers)Journal of Public Health Management and Practice (4 papers)Current Developments in Nutrition (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Ping Du
89 papers receiving 2.0k citations
Ping Du's Hit Papers
Peers
Comparison fields: 5 of 151
- Infectious Diseases 357
- Applied Microbiology and Biotechnology 36
- Modeling and Simulation 66
- Physiology 323
- Microbiology 73
Countries citing papers authored by Ping Du
This map shows the geographic impact of Ping Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Du more than expected).
Fields of papers citing papers by Ping Du
This network shows the impact of papers produced by Ping Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Du. The network helps show where Ping Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis Hit paper breakdown → | 2021 | 183 |
| 2 | 2019 | 171 | |
| 3 | 2006 | 107 | |
| 4 | 2019 | 79 | |
| 5 | 2013 | 67 | |
| 6 | 2015 | 58 | |
| 7 | 2006 | 56 | |
| 8 | 2018 | 55 | |
| 9 | 2015 | 53 | |
| 10 | 1999 | 48 | |
| 11 | 2020 | 47 | |
| 12 | 2019 | 47 | |
| 13 | 2015 | 45 | |
| 14 | 2020 | 43 | |
| 15 | 2010 | 39 | |
| 16 | 2020 | 36 | |
| 17 | 2011 | 35 | |
| 18 | 2013 | 35 | |
| 19 | 2021 | 34 | |
| 20 | 2019 | 33 |
About Ping Du
Ping Du is a scholar working on Epidemiology, Molecular Biology, Infectious Diseases, Physiology and Hepatology, having authored 89 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), HIV, Drug Use, Sexual Risk (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Platelet Disorders and Treatments (6 papers), Reproductive tract infections research (6 papers), Smoking Behavior and Cessation (6 papers), HIV/AIDS Research and Interventions (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Infectious Diseases (357 citations), Applied Microbiology and Biotechnology (36 citations), Modeling and Simulation (66 citations), Physiology (323 citations) and Microbiology (73 citations). Ping Du has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Paddy Ssentongo, Vernon M. Chinchilli, Anna E. Ssentongo, Jintong Liu, Lei Zhang, Jianping Lei, Emily S. Heilbrunn, Hugh D. C. Smyth, Ju Du and Shailesh Advani. Their work appears in journals such as Sexually Transmitted Diseases, American Journal of Infection Control, Journal of Public Health Management and Practice, Current Developments in Nutrition and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.